Your browser doesn't support javascript.
loading
Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.
Voskuilen, Charlotte S; Seiler, Roland; Rink, Michael; Poyet, Cédric; Noon, Aidan P; Roghmann, Florian; Necchi, Andrea; Aziz, Atiqullah; Lavollé, Alexandre; Young, Matthew J; Marks, Phillip; Saba, Karim; van Rhijn, Bas W G; Fransen van de Putte, Elisabeth E; Ablat, Jason; Black, Peter C; Sosnowski, Roman; Dobruch, Jakub; Kumar, Pardeep; Jallad, Samer; Catto, James W F; Xylinas, Evanguelos; Hendricksen, Kees.
Afiliación
  • Voskuilen CS; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: c.voskuilen@nki.nl.
  • Seiler R; Department of Urology, University Hospital Bern, Bern, Switzerland.
  • Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Poyet C; Department of Urology, University Hospital Zurich, Zurich, Switzerland.
  • Noon AP; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Roghmann F; Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany.
  • Necchi A; Department of Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Aziz A; Department of Urology, University Medical Center Rostock, Rostock, Germany.
  • Lavollé A; Department of Urology, Cochin Hospital, Paris Descartes University, Paris, France.
  • Young MJ; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Marks P; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Saba K; Department of Urology, University Hospital Zurich, Zurich, Switzerland.
  • van Rhijn BWG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Fransen van de Putte EE; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Ablat J; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Black PC; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Sosnowski R; Department of Uro-oncology, Institute of Oncology, Warsaw, Poland.
  • Dobruch J; Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.
  • Kumar P; Department of Urology, Royal Marsden Hospital NHS Trust, London, UK.
  • Jallad S; Department of Urology, Royal Marsden Hospital NHS Trust, London, UK.
  • Catto JWF; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Xylinas E; Department of Urology, Cochin Hospital, Paris Descartes University, Paris, France.
  • Hendricksen K; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Eur Urol Focus ; 6(6): 1226-1232, 2020 11 15.
Article en En | MEDLINE | ID: mdl-30559065
ABSTRACT

BACKGROUND:

Urothelial carcinoma arising in a bladder diverticulum (UCBD) is uncommon, and data on treatment and outcome are sparse.

OBJECTIVE:

To analyze clinicopathological characteristics of UCBD and to compare outcome after radical cystectomy (RC) and partial cystectomy (PC). DESIGN, SETTING, AND

PARTICIPANTS:

Data of 115 UCBD patients treated with RC (n=81) or PC (n=34) between 2000 and 2016 were collected from 11 institutional databases and were analyzed retrospectively. Median follow-up was 5.0yr (95% confidence interval [CI] 4.0-6.2). OUTCOME MEASUREMENTS AND STATISTICAL

ANALYSIS:

Upstaging of tumor stage at diagnostic transurethral resection (TUR) to the RC/PC specimen was investigated. Overall survival (OS) and metastasis-free survival (MFS) after RC and PC were analyzed using Kaplan-Meier estimates, and compared using the log-rank test. Intravesical recurrences after PC were reported. A multivariable Cox proportional-hazard model was used to identify factors associated with OS. RESULTS AND

LIMITATIONS:

There were no statistically significant differences in clinicopathological characteristics between RC and PC groups. Fifty-five percent of patients with cTa/is/1 at diagnostic TUR had ≥pT2 tumors at RC/PC. Five-year OS and MFS were, respectively, 62% and 66% for RC and 66% and 55% for PC (p=0.9 and p=0.6). Intravesical tumor recurrence was seen in six of 34 (18%) PC patients. In multivariable analysis, positive surgical margins and extravesical disease (≥pT2) were associated with worse OS, whereas treatment modality was not (RC reference; PC hazard ratio 0.94, [95% CI 0.47-1.90], p=0.9).

CONCLUSIONS:

Upstaging of UCBD was frequent, indicating an inaccuracy in clinical staging. We found no differences in OS or MFS between PC and RC groups; therefore, PC may represent a feasible surgical alternative to RC in selected UCBD patients. PATIENT

SUMMARY:

In this report, we looked at the treatment of urothelial carcinoma arising in a bladder diverticulum (UCBD). We found that bladder-sparing treatment by partial cystectomy may be an alternative to radical cystectomy in carefully selected UCBD patients.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vejiga Urinaria / Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Cistectomía / Divertículo Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vejiga Urinaria / Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Cistectomía / Divertículo Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article